INVESTOR ALERT: Faruqi & Faruqi, LLP Continues Investigation of Potential Securities Claims Against Bionics (BBNX)

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Beta Bionics, Inc. following a significant decline in its stock price due to disappointing performance metrics [2][4]. Group 1: Company Performance - On January 9, 2026, Beta Bionics' shares dropped approximately $11.85, or 37.04%, closing at $20.14 after the company reported preliminary fourth-quarter 2025 performance metrics that did not meet market expectations [4]. - The decline was attributed to lower-than-expected new patient starts for its iLet automated insulin delivery system, raising concerns about near-term adoption trends and revenue growth [4]. Group 2: Legal Investigation - Faruqi & Faruqi, LLP, a prominent national securities law firm, is encouraging investors who suffered significant losses in Beta Bionics stock or options to reach out for potential claims [1][2]. - The firm has a history of recovering hundreds of millions of dollars for investors since its establishment in 1995 [3].